[go: up one dir, main page]

MD3250G2 - Method of keratoconjunctivitis sicca syndrome treatment - Google Patents

Method of keratoconjunctivitis sicca syndrome treatment Download PDF

Info

Publication number
MD3250G2
MD3250G2 MDA20060189A MD20060189A MD3250G2 MD 3250 G2 MD3250 G2 MD 3250G2 MD A20060189 A MDA20060189 A MD A20060189A MD 20060189 A MD20060189 A MD 20060189A MD 3250 G2 MD3250 G2 MD 3250G2
Authority
MD
Moldova
Prior art keywords
keratoconjunctivitis sicca
sicca syndrome
syndrome treatment
treatment
keratoconjunctivitis
Prior art date
Application number
MDA20060189A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD3250F1 (en
Inventor
Мохаммад Абдулмаджед Х.
Владимир БОИШТЯНУ
Валериу РУДИК
Original Assignee
Мохаммад Абдулмаджед Х.
Владимир БОИШТЯНУ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мохаммад Абдулмаджед Х., Владимир БОИШТЯНУ filed Critical Мохаммад Абдулмаджед Х.
Priority to MDA20060189A priority Critical patent/MD3250G2/en
Publication of MD3250F1 publication Critical patent/MD3250F1/en
Publication of MD3250G2 publication Critical patent/MD3250G2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention refers to medicine, namely to ophthalmology and is meant for treatment of patients with keratoconjunctivitis sicca syndrome.The method, according to the invention, consists in that into the conjunctival sac there is instilled 0,5% BioR remedy for 2 drops 4…6 times a day during 10…12 days.
MDA20060189A 2006-07-14 2006-07-14 Method of keratoconjunctivitis sicca syndrome treatment MD3250G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20060189A MD3250G2 (en) 2006-07-14 2006-07-14 Method of keratoconjunctivitis sicca syndrome treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20060189A MD3250G2 (en) 2006-07-14 2006-07-14 Method of keratoconjunctivitis sicca syndrome treatment

Publications (2)

Publication Number Publication Date
MD3250F1 MD3250F1 (en) 2007-02-28
MD3250G2 true MD3250G2 (en) 2007-10-31

Family

ID=37845204

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20060189A MD3250G2 (en) 2006-07-14 2006-07-14 Method of keratoconjunctivitis sicca syndrome treatment

Country Status (1)

Country Link
MD (1) MD3250G2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2546922C1 (en) * 2014-04-17 2015-04-10 Роман Валерьевич Калмыков Method of "dry eye" syndrome treatment

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2126669C1 (en) * 1997-04-25 1999-02-27 Новокузнецкий государственный институт усовершенствования врачей Method of treatment of patients with xerophthalmus syndrome

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2126669C1 (en) * 1997-04-25 1999-02-27 Новокузнецкий государственный институт усовершенствования врачей Method of treatment of patients with xerophthalmus syndrome

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Бржевский В.В., Сомов Е.Е. Роговично-конъюнктивальный ксероз (диагностика, клиника, лечение), Санкт-Петербург, 2003, с. 76-86 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2546922C1 (en) * 2014-04-17 2015-04-10 Роман Валерьевич Калмыков Method of "dry eye" syndrome treatment

Also Published As

Publication number Publication date
MD3250F1 (en) 2007-02-28

Similar Documents

Publication Publication Date Title
NZ606825A (en) Methods and compositions for treating complement-associated disorders
RU2010133480A (en) TREATMENT OF THE METASTATIC STAGE OF PROSTATE CANCER DEGARELIX
IL172082A0 (en) Foamable pharmaceutical compositions and methods for treating a disorder
WO2008039218A3 (en) Inhibitors of bruton's tyrosine kinase
WO2008050329A3 (en) Novel sirnas and methods of use thereof
WO2007143607A3 (en) Method of treating atrophic vaginitis
EP1933833B8 (en) Therapy for the treatment of overactive bladder
WO2007002572A3 (en) Nattokinase for reducing whole blood viscosity
WO2009020643A3 (en) Method for inhibiting inflammation and pre-inflammatory cytokine/chemokine expression using a ghrelin analogue
WO2007138466A3 (en) Pharmaceutical compositions comprising meloxicam and tramadol combination
ATE284698T1 (en) ACTIVATION OF NATURAL KILLER CELLS BY ADENOSINE A3 RECEPTOR AGONISTS
ZA200810124B (en) Pharmaceutical combination comprising 3-(3-dimethyl-amino-1-ethyl-2-methyl-propyl)-phenol and Paracetamol
WO2009109654A8 (en) 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1
ATE521343T1 (en) COMPOSITIONS OF RASAGILIN THAT DISSOLVE IN THE MOUTH
CL2023000296A1 (en) Use of dexpramipexole for the treatment of moderate to severe asthma
NZ593199A (en) Milnacipran for the long-term treatment of fybromyalgia syndrome
WO2002047673A3 (en) Methods and compositions to treat conditions associated with neovascularization
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
WO2020160493A3 (en) Compounds, compositions and methods for treatment of myopia
MX2022012001A (en) Preventative treatment of migraine.
WO2006002096A3 (en) Low doses of l-citrulline for treating diseases
MD3250G2 (en) Method of keratoconjunctivitis sicca syndrome treatment
EP4523750A3 (en) Methods of reducing cerebrovascular events in patients with fabry disease
AU2020299145A8 (en) Compositions and methods for treating eye diseases
WO2004012677A3 (en) Methods and compositions to treat conditions associated with neovascularization

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees